erlotinib has been researched along with jq1 compound in 3 studies
| Studies (erlotinib) | Trials (erlotinib) | Recent Studies (post-2010) (erlotinib) | Studies (jq1 compound) | Trials (jq1 compound) | Recent Studies (post-2010) (jq1 compound) |
|---|---|---|---|---|---|
| 221 | 0 | 180 | 109 | 0 | 105 |
| Protein | Taxonomy | erlotinib (IC50) | jq1 compound (IC50) |
|---|---|---|---|
| Histone deacetylase 3 | Homo sapiens (human) | 0.291 | |
| Bromodomain-containing protein 4 | Homo sapiens (human) | 0.142 | |
| Cytochrome P450 1A2 | Homo sapiens (human) | 0.82 | |
| Cytochrome P450 3A4 | Homo sapiens (human) | 0.0527 | |
| Bromodomain-containing protein 2 | Homo sapiens (human) | 0.0959 | |
| Histone deacetylase 4 | Homo sapiens (human) | 0.291 | |
| Histone deacetylase 1 | Homo sapiens (human) | 0.291 | |
| Bromodomain-containing protein 3 | Homo sapiens (human) | 0.0573 | |
| Bromodomain testis-specific protein | Homo sapiens (human) | 0.1902 | |
| Histone deacetylase 7 | Homo sapiens (human) | 0.291 | |
| Histone deacetylase 2 | Homo sapiens (human) | 0.291 | |
| CREB-binding protein | Homo sapiens (human) | 9.573 | |
| Polyamine deacetylase HDAC10 | Homo sapiens (human) | 0.291 | |
| Histone deacetylase 11 | Homo sapiens (human) | 0.291 | |
| Histone deacetylase 8 | Homo sapiens (human) | 0.291 | |
| Histone deacetylase 6 | Homo sapiens (human) | 0.291 | |
| Histone deacetylase 9 | Homo sapiens (human) | 0.291 | |
| Histone deacetylase 5 | Homo sapiens (human) | 0.291 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ | 1 |
| Duan, G; Liu, T; Wan, Y; Xia, C; Xiao, Y | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
1 review(s) available for erlotinib and jq1 compound
| Article | Year |
|---|---|
Dual-Target Inhibitors Based on HDACs: Novel Antitumor Agents for Cancer Therapy.
Topics: Antineoplastic Agents; DNA Damage; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Neoplasms; Protein Kinases; Proteins; Structure-Activity Relationship; Topoisomerase Inhibitors | 2020 |
2 other study(ies) available for erlotinib and jq1 compound
| Article | Year |
|---|---|
Identification of potent Yes1 kinase inhibitors using a library screening approach.
Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship | 2013 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |